Periodic Report. At least once a year we will send you a report for this Policy. It will show: (1) the current Death Benefit; (2) the current Policy Account Value; (3) the Guaranteed Account Value; (4) the Loan Account Value; (5) the value in each Subaccount (6) premiums paid since the last report; (7) charges deducted since the last report; (8) any partial withdrawals of Net Cash Surrender Value since the last report; (9) any policy loans and accrued interest; (10) the current Net Cash Surrender Value; (11) any other information that may be required when and where this Policy is delivered. You may ask for a similar report at some other time. We have the right to make a reasonable charge for the reports that you ask for, and to limit the scope and frequency of such reports.
Periodic Report. The Bank shall have received a current Accounts Receivable Report and a current Inventory Report (as required by Section 5.6 ("Financial Information") sufficient in form and substance to calculate and verify the Borrowing Base.
Periodic Report. If an individual financial statement is not submitted for a reporting period, it may be included in the periodic financial report for the next reporting period. • The individual financial statements of the last reporting period must also detail the receipts of the action. • the ‘periodic summary financial statement’, will be created automatically by the system, consolidating the individual financial statements for the reporting period concerned and including — except for the last reporting period — the request for interim payment. Request for payment of the balance / Final Financial Report: • final summary financial statement created automatically by the system, consolidating the individual financial statements for all reporting periods and including the request for payment of the balance and • certificate on the financial statements (CFS drawn up in accordance with Annex 5) for each beneficiary, if the cumulative amount of payments to beneficiary requests as reimbursement of actual costs is EUR 325 000 or more and the maximum EU contribution indicated for that beneficiary in the estimated budget as reimbursement of actual costs is EUR 750 000 or more Payments –reimbursement actual costs • Pre-financing - fixed amount (up to 20% of maximum grant) May be conditional to receipt of pre financing guarantee From a bank or an approved financial institution or a third party Pre financing may only be distribute between beneficiaries if: 90% of the beneficiaries have acceded to the Agreement and only to those having acceded • Interim Payment Interim payments reimburse the eligible costs incurred for the implementation of the action during the corresponding reporting periods. Payment is subject to the approval of the periodic report Payments –reimbursement of actual costs • Payment of the Balance reimburses the remaining part of eligible costs incurred for the implementation of the action Payment is subject to the approval of the final report • If the total amount of earlier payments is greater than the final grant amount the payment of the balance takes the form of a recovery. Reports & Payments • Costs must be reported in EURO (EUR) • Exchange rate for beneficiaries with accounting in a currency other than euro- average of the daily exchange rates, calculated over the corresponding reporting period. • Language of Reports – English • Payment delay – 60 days (30 days for pre-financing) • Suspension of payment deadline Reports do not comply wi...
Periodic Report. Where the Company provides the investment service of Portfolio Management it shall ensure the periodic assessment of suitability and inform the Retails Clients, through the delivery of the Periodic Report. The Periodic Report shall contain an updated statement of how the investments performed meet the preferences, objectives and other characteristics of the Retail Client. The Company will provide Clients with such a report on a monthly basis.
Periodic Report. Within 30 days of each Reporting Date (and, if applicable, within 30 days of the date of the State's request under clause 8.9), the Grantee must provide a report to the State, in a form satisfactory to the State, which includes the following:
Periodic Report. The Parties, in accordance with the CFR, shall produce the US PR for their respective Product.
Periodic Report. The Operator shall prepare and submit a periodic report on the performance of the IANA Numbering Services that documents standard operating procedures, including a description of the techniques, methods, software, and tools employed in the performance of the IANA Numbering Services. The Operator shall submit the report to the RIRs at each anniversary date of the Commencement Date, and for the final periodic report, no later than 30 days after termination of the Agreement. For clarity, this provision survives any termination of the Agreement.
Periodic Report. The City may require a Member on FMLA leave to report periodically on the Member’s status and intent to return to work. Such reporting periods shall be reasonable. If a Member gives notice of intent not to return to work, this notice shall be considered a resignation, and the City’s obligations under FMLA to maintain health care/insurance benefits (subject to COBRA requirements) and to return the Member to work cease.
Periodic Report. A report of Adverse Events prepared and submitted on a periodic basis to Regulatory Authorities that contains collated data on single case reports and addresses the risk-benefit profile of the Medicinal Product. Periodicity of reporting varies according to local rules and the nature of the report e.g. submitted pursuant to Applicable Laws and regulatory requirements for trial or post-authorisation requirements. Periodic Safety Update Report (“PSUR”): A report of Adverse Events prepared and submitted on a periodic basis to Regulatory Authorities PSUR includes updates on urgent Safety Issues, major signal detection/evaluation, and changes in efficacy. Pharmacovigilance: The science and activities relating to the detection, collection, recording assessment, understanding, reporting, prevention and/or management of AEs or other Safety Issues related to Medicinal Products and their use. Post-Authorisation Safety Study (“PASS”): Any study carried out in accordance with the terms of the MA, conducted with the aim of identifying or quantifying a safety hazard relating to the authorised Medicinal Product.
Periodic Report. The Board shall cause any annual or periodic report required under law to be prepared and delivered to an office of this state or to the Promoters of this Corporation, to be so prepared and delivered within the time limits set by law. The Board shall cause an annual report to be prepared within 120 days after the end of the corporation's fiscal year. That report shall contain the following information in appropriate detail:
